Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,243 | 185 | 76.1% |
| Travel and Lodging | $1,633 | 6 | 19.9% |
| Education | $302.86 | 2 | 3.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.50 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,605 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $707.13 | 27 | $0 (2024) |
| Amgen Inc. | $569.91 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $412.37 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $390.96 | 17 | $0 (2024) |
| Novo Nordisk Inc | $341.26 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $306.80 | 22 | $0 (2024) |
| Medtronic, Inc. | $224.11 | 9 | $0 (2024) |
| Lilly USA, LLC | $214.44 | 8 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $170.86 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,459 | 105 | E.R. Squibb & Sons, L.L.C. ($502.70) |
| 2023 | $1,422 | 51 | Abbott Laboratories ($361.20) |
| 2022 | $3,286 | 36 | Abbott Laboratories ($2,859) |
| 2021 | $32.41 | 2 | E.R. Squibb & Sons, L.L.C. ($32.41) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $144.70 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $130.07 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.83 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Not Applicable | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $131.58 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,650 | 3,041 | $879,512 | $227,906 |
| 2022 | 10 | 393 | 547 | $164,902 | $44,134 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 358 | 798 | $352,716 | $91,351 | 25.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 207 | 223 | $154,316 | $38,061 | 24.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 378 | $102,060 | $26,912 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 380 | 808 | $42,016 | $10,547 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 87 | $35,322 | $9,451 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 67 | 73 | $32,631 | $8,491 | 26.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 40 | 40 | $27,560 | $7,304 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $27,792 | $6,847 | 24.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 37 | $21,867 | $5,579 | 25.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 21 | $15,435 | $4,132 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 16 | $9,538 | $2,478 | 26.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 178 | 276 | $2,484 | $2,302 | 92.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $8,262 | $2,138 | 25.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 34 | 34 | $8,364 | $2,027 | 24.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 24 | $6,672 | $1,763 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $6,260 | $1,676 | 26.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 27 | $5,346 | $1,429 | 26.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 18 | 22 | $5,698 | $1,377 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 16 | $5,312 | $1,351 | 25.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 28 | $4,844 | $1,291 | 26.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 17 | 17 | $4,507 | $1,273 | 28.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 30 | $510.00 | $126.00 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 130 | $57,980 | $15,491 | 26.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 43 | 43 | $30,745 | $8,201 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 94 | $23,030 | $6,175 | 26.8% |
About Dr. Navid Ahmed, M.D
Dr. Navid Ahmed, M.D is a Cardiovascular Disease healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1659727048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Navid Ahmed, M.D has received a total of $8,200 in payments from pharmaceutical and medical device companies, with $3,459 received in 2024. These payments were reported across 194 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,243).
As a Medicare-enrolled provider, Ahmed has provided services to 2,043 Medicare beneficiaries, totaling 3,588 services with total Medicare billing of $272,040. Data is available for 2 years (2022–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Great Neck, NY
- Active Since 05/04/2016
- Last Updated 04/17/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1659727048
Products in Payments
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $2,433
- CAMZYOS (Drug) $451.42
- Repatha (Biological) $425.21
- XARELTO (Drug) $412.37
- VERQUVO (Drug) $315.24
- CARDIOMEMS (Device) $276.10
- ENSITE PRECISION (Device) $228.11
- ELIQUIS (Drug) $227.61
- AVEIR (Device) $208.27
- LEQVIO (Drug) $171.54
- Arcalyst (Drug) $170.86
- ACUSON Redwood Diagnostic Ultrasound System (Device) $169.88
- JARDIANCE (Drug) $161.37
- MERLIN@HOME (Device) $156.79
- GALLANT (Device) $155.84
- WATCHMAN FLX (Device) $146.46
- MULTAQ (Drug) $143.80
- ENTRESTO (Drug) $135.26
- MOUNJARO (Drug) $128.12
- Cologuard Collection Kit (Device) $107.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Great Neck
Dr. Evan Schwarzwald, D.o, D.O
Cardiovascular Disease — Payments: $449,880
Dr. Steven Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $78,555
Dr. David Stern, M.d, M.D
Cardiovascular Disease — Payments: $25,959
Dr. Lauren Boglioli, Md Facc Facp Fccp, MD FACC FACP FCCP
Cardiovascular Disease — Payments: $15,130
Dr. Joel Goldberg, Md, MD
Cardiovascular Disease — Payments: $8,960
Dr. William Blau, Md, MD
Cardiovascular Disease — Payments: $7,393